Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Particle and Fibre Toxicology | journal | 3.221 Q1 | 119 | 49 | 106 | 2648 | 1166 | 102 | 11.00 | 54.04 | 37.39 | |
2 | International Journal of Neuropsychopharmacology | journal | 2.131 Q1 | 125 | 127 | 377 | 7517 | 1865 | 359 | 4.78 | 59.19 | 41.38 | |
3 | PharmacoEconomics | journal | 1.798 Q1 | 118 | 88 | 284 | 3813 | 992 | 237 | 3.09 | 43.33 | 44.49 | |
4 | CNS Neuroscience and Therapeutics | journal | 1.604 Q1 | 91 | 164 | 170 | 6428 | 793 | 152 | 4.77 | 39.20 | 38.27 | |
5 | Protein and Cell | journal | 1.603 Q1 | 94 | 111 | 253 | 5196 | 737 | 237 | 2.91 | 46.81 | 36.66 | |
6 | Human Genomics | journal | 1.462 Q1 | 68 | 26 | 115 | 1348 | 396 | 99 | 2.71 | 51.85 | 38.20 | |
7 | Expert Review of Vaccines | journal | 1.331 Q1 | 105 | 150 | 465 | 8819 | 1801 | 378 | 3.92 | 58.79 | 37.47 | |
8 | Journal of Nanobiotechnology | journal | 1.169 Q1 | 109 | 45 | 101 | 1810 | 470 | 101 | 4.69 | 40.22 | 31.72 | |
9 | Clinical and Translational Science | journal | 1.086 Q1 | 60 | 78 | 301 | 1952 | 470 | 186 | 1.78 | 25.03 | 43.50 | |
10 | Cardiovascular Therapeutics | journal | 1.009 Q2 | 54 | 74 | 153 | 4591 | 437 | 143 | 2.79 | 62.04 | 33.33 | |
11 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.990 Q2 | 57 | 53 | 140 | 1992 | 357 | 137 | 2.74 | 37.58 | 32.65 | |
12 | BMC Chemical Biology | journal | 0.860 Q2 | 21 | 5 | 16 | 189 | 47 | 16 | 3.22 | 37.80 | 25.00 | |
13 | Chinese Medicine | journal | 0.813 Q2 | 56 | 28 | 108 | 951 | 371 | 100 | 3.48 | 33.96 | 36.54 | |
14 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 68 | 28 | 93 | 1970 | 302 | 89 | 4.05 | 70.36 | 39.29 | |
15 | Antiviral Chemistry and Chemotherapy | journal | 0.734 Q2 | 59 | 23 | 57 | 1092 | 125 | 54 | 1.90 | 47.48 | 29.13 | |
16 | Drug Delivery | journal | 0.680 Q1 | 95 | 44 | 206 | 1812 | 433 | 195 | 2.24 | 41.18 | 44.23 | |
17 | Journal of Occupational Medicine and Toxicology | journal | 0.476 Q3 | 47 | 19 | 101 | 1232 | 168 | 100 | 1.74 | 64.84 | 35.71 | |
18 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.448 Q3 | 92 | 115 | 405 | 3807 | 596 | 403 | 1.37 | 33.10 | 36.74 | |
19 | Pharmaceutical Biology | journal | 0.425 Q2 | 88 | 186 | 593 | 6935 | 877 | 588 | 1.64 | 37.28 | 40.29 | |
20 | Journal of Negative Results in BioMedicine | journal | 0.352 Q1 | 25 | 16 | 38 | 476 | 44 | 37 | 1.04 | 29.75 | 37.04 | |
21 | Drugs in R and D | journal | 0.308 Q3 | 54 | 25 | 58 | 670 | 78 | 54 | 1.34 | 26.80 | 26.50 | |
22 | DARU, Journal of Pharmaceutical Sciences | journal | 0.299 Q3 | 58 | 100 | 162 | 3124 | 181 | 161 | 1.01 | 31.24 | 34.82 | |
23 | Chemical Speciation and Bioavailability | journal | 0.281 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
24 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.257 Q4 | 41 | 67 | 209 | 1835 | 114 | 184 | 0.56 | 27.39 | 47.12 | |
25 | EPMA Journal | journal | 0.208 Q3 | 52 | 13 | 107 | 879 | 106 | 96 | 0.99 | 67.62 | 32.77 | |
26 | Journal of Pharmaceutical Policy and Practice | journal | 0.164 Q3 | 32 | 15 | 33 | 439 | 9 | 24 | 0.27 | 29.27 | 37.84 | |
27 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 30 | 29 | 1504 | 63 | 29 | 2.36 | 50.13 | 29.63 | ||
28 | BMC pharmacology & toxicology | journal | 43 | 21 | 0 | 746 | 0 | 0 | 0.00 | 35.52 | 46.27 | ||
29 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | 60.00 | ||
30 | Emerging Microbes and Infections | journal | 94 | 30 | 0 | 1498 | 0 | 0 | 0.00 | 49.93 | 35.16 | ||
31 | Environmental Pollutants and Bioavailability | journal | 39 | 31 | 88 | 1298 | 52 | 88 | 0.72 | 41.87 | 33.33 | ||
32 | F1000Research | journal | 105 | 47 | 0 | 1266 | 0 | 0 | 0.00 | 26.94 | 31.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®